D. Zehentgruber et al. / Journal of Molecular Catalysis B: Enzymatic 84 (2012) 62–64
63
either 50 mM sodium formate or 2-propanol were added and the
reaction was started by adding recombinant cells in concentra-
tion of 20 g L−1 (CWW). Samples were taken periodically and the
reaction was stopped by their heating at 99 ◦C. Prior GC analysis ␣-
ionone was added as internal standard and the ionone derivatives
extracted with ethyl acetate.
2.3. Product analysis
GC measurements were carried out using an Agilent
7683 instrument (Agilent, Palo Alto, USA) with a Lipodex E
25 m × 0.25 mm column (Macherey & Nagel, Düren, Germany). A
temperature gradient was applied to separate the enantiomers
(R)- and (S)-4-hydroxy--ionone (1 min 130 ◦C; ꢀ1 ◦C min−1 till
150 ◦C; 6 min 150 ◦C; ꢀ1 ◦C min−1 till 170 ◦C). ␣-Ionone was added
as internal standard (IS).
Fig. 2. Conversion of -ionone by an E. coli strain expressing P450 BM-3 variant.
Conditions: 50 mM KPi pH 6.5, 20 g L−1 E. coli P450 BM-3 + FDH, 1 mM -ionone,
1 vol% ethanol, 50 mM sodium formate, 20 ◦C. Second axis: area substance/area
internal standard (IS).
NMR experiments were done on
a 600 MHz instrument
(Bruker, Rheinstetten, Germany): 4-oxo--ionone: 1H NMR (CDCl3,
600 MHz): ı = 7.25 (d, J = 18 Hz, 1H, CH), 6.19 (d, J = 18 Hz, 1H, CH),
2.54 (t, J = 6.3 Hz 2H, CH2), 2.35 (s, 3H, CH3), 1.91 (t, 2H, CH2), 1.82
(s, 3H, CH3) 1.2 ppm (s, 6H, 2CH3).
Both ADH and FDH could efficiently be used for cofactor regener-
ation. However in case of ADH lower cosubstrate concentrations
already led to an improved hydroxylation rate, pointing out that
it is the preferred cofactor regeneration system [11]. To avoid any
influence from the growth of the bacteria on the hydroxylation, the
biotransformation was performed with resting cells in potassium
phosphate buffer. After cultivating the respective E. coli strain in
shake flasks the cells were harvested by centrifugation and washed
biotransformation an eeR of 65% in favor of the (R)-4-hydroxy--
ionone was observed. Over the reaction time the eeR of the desired
product dropped until a racemic mixture of 4-hydroxy--ionone
was reached (Fig. 2). Simultaneously, the concentration of the
desired product decreased and side product formation occurred.
Hence we assumed that the conversion of 4-hydroxy--ionone to
the unknown side product leads to the loss in enantioselectivity.
By NMR experiments the side product could be identified as
the oxidation product of 4-hydroxy--ionone, 4-oxo--ionone.
The overoxidation is caused by the P450 BM-3 itself, as 4-oxo--
ionone formation occurs only when the respective P450 enzyme
is expressed. This was confirmed in control experiments, where 4-
hydroxy--ionone was used as substrates for cells only expressing
either ADH or FDH. In these cases, no formation of the oxidation
product could be observed. Further control experiments were per-
formed in vitro with cell lysate containing the P450 BM-3 mutant.
Over the period of time >2 h up to 8% 4-oxo--ionone was formed.
This kind of overoxidation has already been observed for several
cytochrome P450 catalyzed reactions. It is even of particular inter-
est for the production of nootkatone [12], a sesquiterpene that is
important in the flavour industry.
13C NMR (CDCl3, 600 MHz): ı = 197 (C O), 189 (C O), 157 (Cq),
140 (CH), 133 (CH), 130 (Cq), 37 (CH2), 34.5 (CH2), 34 (CH3), 29
(CH3) 27.9 (2 × CH3), 13.4 ppm (CH3).
3. Results and discussion
Initially a GC method for the separation of (R)- and (S)-4-
hydroxy--ionone was developed using a Lipodex E column. By
applying a temperature gradient, separation of both enantiomers
formation was studied.
An Escherichia coli strain expressing the P450 BM-3 variant A74G
F87V L188Q R966D W1046S, a mutant previously used for the oxi-
dation of -ionone (A74G F87V L188Q [4]) and with altered cofactor
preference (R966D W1046S [9]), together with either an alcohol
drogenase (FDH) from Mycobacterium vaccae 10 to implement an
enzyme coupled cofactor regeneration (Fig. 1) was used as whole
cell biocatalyst. Similar to P450 BM-3 catalyzed hydroxylation of
(+)-␣-pinene [10] enzyme coupled cofactor regeneration signif-
icantly increased the overall hydroxylation activity of -ionone.
To circumvent side product formation and a decreasing eeR of
(R)-4-OH--ionone during -ionone conversion a short reaction
time and a low biocatalyst concentration must be applied, as the
overoxidation to the ketone is slower than the desired hydroxy-
lation reaction. Therefore, the biotransformation was performed
under optimized conditions in presence of only 2 g L−1 cells instead
of 20 g L−1 and was stopped after 120 min. Additionally, the ADH
the eeR remained constant with a value of 65% and the amount of 4-
oxo--ionone formed was lower than 1%, indicating that the side
reaction could be circumvented under these reaction conditions
(Fig. 3). However conversion did not exceed 50% due to product
inhibition, which was identified in a study on the kinetic parame-
ters of the hydroxylation of -ionone. This investigation revealed
the following kinetic parameters: vmax: 2.75 0.21 U 4-OH--
ionone gwcw−1; KM: 0.65 0.15 mM, KIP: 0.034 0.015 mM [11].
Fig. 1. Scheme of the whole-cell biocatalyst expressing P450 BM-3 variant together
with FDH/ADH for enzyme coupled cofactor regeneration.